This inventor holds 20 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Kyorin Pharmaceutical Co., Ltd., Kyorin Pharameuticals Co., Ltd.. Active years: 1993-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nogi, JP (1993 - 1994)
- Oyama, JP (2003 - 2004)
- Tochigi, JP (1999 - 2011)
- Nogi-machi, JP (1999 - 2018)
Company Filing History:

Years Active: 1993-2018
Areas of Expertise:
Title: Innovations and Contributions of Koji Murakami
Introduction
Koji Murakami, a prolific inventor based in Tochigi, Japan, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 20 patents, Murakami's work focuses primarily on innovative methods and compounds that enhance therapeutic outcomes.
Latest Patents
Among his latest innovations are two notable patents related to AMPK activators. The first, titled "AMPK activator screening method," outlines a unique method for identifying AMPK activators by assessing the inhibition of the interaction between prohibitin and AMPK. The second patent describes an active compound that acts as an AMPK activator by disrupting the prohibitin-AMPK complex, thereby demonstrating novel therapeutic potential.
Murakami has also introduced novel bicycloester derivatives, which are characterized by their high DPP-IV inhibitory activity. These compounds, detailed by the general formula (1), include pharmaceutically acceptable salts, showcasing their relevance in medical applications. For instance, one example is (2S,4S)-1-[[(N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, indicating his expertise in creating complex pharmaceutical compounds.
Career Highlights
Throughout his career, Koji Murakami has worked with esteemed organizations such as Kyorin Pharmaceutical Co., Ltd. and Kyorin Pharmaceuticals Co., Ltd. His dedication and innovative mindset have led to advancements in the pharmaceutical industry, solidifying his reputation as a leading inventor.
Collaborations
Murakami has collaborated with notable colleagues, including Masaki Tsunoda and Masahiro Nomura. These partnerships have likely fostered an environment of shared expertise and innovation, contributing to the successful development of his groundbreaking patents.
Conclusion
Koji Murakami's contributions to the pharmaceutical field, exemplified by his recent patents and collaborative efforts, underscore his position as a significant inventor. His innovative approach to drug discovery and development continues to pave the way for new therapeutic solutions, demonstrating the impact of his work on global health advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile